Targovax to Present at NeoAg Summit 2018

Friday, November 16, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

OSLO, Nov. 16, 2018 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat

solid tumors, today announces that CMO Magnus Jäderberg will present at the NeoAg Summit 2018 (formerly Neoantigen Summit) in Boston

NeoAg Summit 2018Date: 16 November 2018 Presenter:

Dr. Magnus Jäderberg, CMOPresentation time: 11:00 ETVenue: Hyatt Regency Cambridge, Boston.

Title: TG01, a neo-antigen specific vaccine targeting RAS mutations in solid tumours

Presentation slides will be available on www.targovax.com/Investors.

For further information, please contact:Renate Birkeli, Investor RelationsPhone: +47-922-61-624Email: renate.birkeli@targovax.com Media and IR enquires:Andreas Tinglum - Corporate Communications (Norway)Phone: +47-9300-1773Email: andreas.tinglum@corpcom.no Simon Conway/Stephanie Cuthbert - FTI Consulting (International)Phone: +44-20-3727-1000Email: Targovax@fticonsulting.com

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/targovax/r/targovax-to-present-at-neoag-summit-2018,c2673975

 

 

Cision View original content:http://www.prnewswire.com/news-releases/targovax-to-present-at-neoag-summit-2018-300751943.html

SOURCE Targovax



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store